- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01180933
Fish Oil and Folate Supplementation During Pregnancy (NUHEAL)
Dietary Supply of Docosahexaenoic Acid (DHA) and 5-methyl-tetrahydro-folate (MTHF) During the Second Half of Pregnancy and Early Infancy
Pregnant women are randomised to supplementation with fish oil, methyl tetrahydro folic acid, both or a placebo during the second half of pregnancy. Biochemical measures are determined in maternal blood during pregnancy and in cord blood.
Non invasive follow up examinations of infants at ages 4, 5.5, 6.5, 7.5, 8, 9 and 9.5 years focus on long term effects of supplementation anthropometric development, neurological development and allergy risk.
Studieöversikt
Status
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- singleton pregnancy
- gestation <20 week at enrollment
- intention to deliver in one of the study centers
- body weight at time of enrollment from 50 kg to 92 kg
Exclusion Criteria:
- serious chronic illness (eg, diabetes, hepatitis)
- use fish oil supplements since the beginning of pregnancy
- use of folate or vitamin B-12 supplements after gestation week 16
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: fish oil
the participating women receive a milk based supplement providing vitamins and mineral as recommended for pregnant women and 500 mg DHA and 150 eicosapentaenoic acid per day from gestational week 22 until delivery
|
400 mg of DHA and 150 mg of eicosapentaenoic acid per day
|
Experimentell: folate
the participating women receive a milk based supplement providing vitamins and mineral as recommended for pregnant women and 400 µg folate (methyltetrahydrofolate)per day from gestational week 22 until delivery
|
400 µg per day
|
Experimentell: fish oil + folate
the participating women receive a milk based supplement providing vitamins and mineral as recommended for pregnant women and 500 mg DHA, 150 mg eicosapentaenoic acid and 400 µg MTHF per day from gestational week 22 until delivery
|
500 mg DHA, 150 mg eicosapentaenoic acid, 400 µg MTHF per day
|
Placebo-jämförare: placebo
the participating women receive a milk based supplement providing vitamins and mineral as recommended for pregnant women from gestational week 22 until delivery
|
only vitamins and minerals as recommended, but no fish oil or folate
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
percentage contribution of docosahexaenoic acid (DHA) to total phospholipid fatty acids in cord blood
Tidsram: labour
|
the biochemical efficacy of supplementation during pregnancy is tested by measuring the DHA content of cord blood phospholipids, as direct supplementation (fish oil) or increased perfusion of the placenta (MTHF) could both influence this parameter
|
labour
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
neurological and cognitive development of the offspring
Tidsram: age 4 years, 5.5 years, 6.5 years, 7.5 years, 8 years, 9 years, 9.5 years
|
non invasive, age adequate, tests of neurological and cognitive function are performed at various ages of the offspring
|
age 4 years, 5.5 years, 6.5 years, 7.5 years, 8 years, 9 years, 9.5 years
|
weight development
Tidsram: age 4 years, 5.5 years, 6.5 years, 8 years, 9.5 years
|
body weight (including weight of fat and non fat mass by bioelectrical impedance at later ages) is determined
|
age 4 years, 5.5 years, 6.5 years, 8 years, 9.5 years
|
height
Tidsram: age 4 years, 5.5 years, 6.5 years, 8 years, 9.5 years
|
body height is measured at ages 4 years, 5.5 years, 6.5 years, 8 years, 9.5 years
|
age 4 years, 5.5 years, 6.5 years, 8 years, 9.5 years
|
life style and diet
Tidsram: age 4 years, 5.5 years, 6.5 years, 7.5 years, 8 years, 9 years, 9.5 years
|
information on medical history, life sytyle and dietary habits is collected via questionnaires and non invasivly collected of biological samples (urine, cheek cells)
|
age 4 years, 5.5 years, 6.5 years, 7.5 years, 8 years, 9 years, 9.5 years
|
electroencephalography (EEG)
Tidsram: age 8 years and 9.5 years
|
at age 8 years and 9.5 years an EEG is obtained while the children are performing defined tests
|
age 8 years and 9.5 years
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Studierektor: Berthold Koletzko, Prof., Dr. von Hauner Childrens Hospital, Ludwig-Maximilians-University Munich
Publikationer och användbara länkar
Allmänna publikationer
- Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jimenez M, Gil A, Rivero M, Veszpremi B, Decsi T, Koletzko BV; Nutrition and Health Lifestyle (NUHEAL) Study Group. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr. 2007 May;85(5):1392-400. doi: 10.1093/ajcn/85.5.1392.
- Catena A, Munoz-Machicao JA, Torres-Espinola FJ, Martinez-Zaldivar C, Diaz-Piedra C, Gil A, Haile G, Gyorei E, Molloy AM, Decsi T, Koletzko B, Campoy C. Folate and long-chain polyunsaturated fatty acid supplementation during pregnancy has long-term effects on the attention system of 8.5-y-old offspring: a randomized controlled trial. Am J Clin Nutr. 2016 Jan;103(1):115-27. doi: 10.3945/ajcn.115.109108. Epub 2015 Nov 11.
- Campoy C, Escolano-Margarit MV, Ramos R, Parrilla-Roure M, Csabi G, Beyer J, Ramirez-Tortosa MC, Molloy AM, Decsi T, Koletzko BV. Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age. Am J Clin Nutr. 2011 Dec;94(6 Suppl):1880S-1888S. doi: 10.3945/ajcn.110.001107. Epub 2011 Aug 17.
- Escolano-Margarit MV, Ramos R, Beyer J, Csabi G, Parrilla-Roure M, Cruz F, Perez-Garcia M, Hadders-Algra M, Gil A, Decsi T, Koletzko BV, Campoy C. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. J Nutr. 2011 Jun;141(6):1216-23. doi: 10.3945/jn.110.129635. Epub 2011 Apr 27.
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 01111
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Perinatal DHA and Folate Status
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)AvslutadDokosahexansyra (DHA) StatusKanada
Kliniska prövningar på fish oil
-
RDC Clinical Pty LtdAvslutadOptimal gastrointestinal absorption av Omega-3Australien
-
Hospital Infantil de Mexico Federico GomezCentro Universitario del Sur, Guadalajara; Instituto de Servicios Descentralizados...AvslutadInsulinresistens | Barnfetma | Metabolisk komplikationMexiko
-
Morris Innovative IncorporatedDeborah Heart and Lung CenterOkändKärlsjukdomarFörenta staterna
-
Assiut UniversitySouth Egypt Cancer InstituteAvslutadAkut myeloid leukemiEgypten
-
Southern California University of Health SciencesAvslutad
-
Baskent UniversityAvslutad
-
Supplement Formulators, Inc.AvslutadInflammationFörenta staterna
-
Supplement Formulators, Inc.AvslutadInflammation | Inflammatorisk responsFörenta staterna
-
Peking UniversityAvslutad
-
Galderma R&DAvslutad